Jeppe Øvli Øvlesen

Jeppe Øvli Øvlesen

CEO, board member

He has previously worked as CEO for ChemoMetec (listed), Pnn Medical and as CFO & VP Business development for Action Pharma. (sold to AbbVie).

A cofounder/founding board member Cetrea (sold to Marque), CLC Bio (sold to Quagen), Monsenso, Enovacor, Biostrip, VikarBasen, Perfusion Tech, Synact Pharma (listed) and TXP Pharma.

Back to team